Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs

ClinicalTrials.gov ID: NCT00004852

Public ClinicalTrials.gov record NCT00004852. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 1:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II/III 48-Week, Randomized, Double-Blind, Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Lamivudine 300mg Once Daily Vs. Lamivudine 150mg BID in Combination With Zidovudine 300mg BID and Efavirenz 600mg Once Daily in Antiretroviral-Naive Adults With HIV-1 Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to look at the safety and effectiveness of receiving lamivudine (3TC) once a day versus twice a day as part of an anti-HIV drug combination.

Study identification

NCT ID
NCT00004852
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Glaxo Wellcome
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 1999 (Type not available)
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 24, 2005

Started 1999

United States locations

U.S. sites
46
U.S. states
19
U.S. cities
35
Facility City State ZIP Site status
Phoenix Body Positive Phoenix Arizona 85016 —
Pacific Oaks Research Beverly Hills California 90211 —
AIDS Healthcare Foundation Los Angeles California 900276069 —
Tower ID Med Associates Los Angeles California 90048 —
Davies Med Ctr / c/o HIV Institute San Francisco California 94114 —
Kaiser Foundation Hospital San Francisco California 94118 —
Harbor - UCLA Med Ctr Torrance California 90509 —
Georgetown Univ Med Ctr Washington D.C. District of Columbia 20007 —
George Washington Univ Med Ctr Washington D.C. District of Columbia 20037 —
IDC Research Initiative Altamonte Springs Florida 32701 —
Bach and Godofsky Bradenton Florida 34205 —
TheraFirst Med Ctrs Inc Fort Lauderdale Florida 33308 —
North Broward Hosp District Fort Lauderdale Florida 33316 —
The Coleman Institute Inc Fort Lauderdale Florida 33334 —
The Coleman Institute Inc Ft. Pierce Florida 34950 —
Kaiser Permanente Infectious Diseases Atlanta Georgia 30339 —
AIDS Research Alliance - Chicago Chicago Illinois 60657 —
Infectious Disease of Indiana Indianapolis Indiana 46218 —
Univ of Kentucky Med Ctr Lexington Kentucky 40536 —
Tulane Univ School of Medicine New Orleans Louisiana 70112 —
Boston Med Ctr / Evans - 556 Boston Massachusetts 021182393 —
Antibiotic Research Associates Kansas City Missouri 64132 —
East Orange Veterans Administration Med Ctr East Orange New Jersey 07018 —
ID Care Inc New Brunswick New Jersey 08901 —
ID Care Inc Princeton New Jersey 08540 —
ID Care Inc Randolph Township New Jersey 07869 —
ID Care Inc Somerville New Jersey 08876 —
Albany Med College / Div of HIV Medicine Albany New York 12208 —
North Shore Univ Hosp / Div of Infectious Diseases Manhasset New York 11030 —
St Vincents Hosp / Clinical Research Program New York New York 10011 —
St Lukes / Roosevelt Hosp / HIV Center New York New York 10019 —
Ohio State Univ Hosp Clinic Columbus Ohio 432101228 —
Oklahoma State University / College of Osteopathic Medicine Tulsa Oklahoma 74107 —
Associates in Med and Mental Health Tulsa Oklahoma 74114 —
Miriam Hosp / Brown Univ Providence Rhode Island 02906 —
Methodist Healthcare Memphis Tennessee 38104 —
Univ of Tennessee Memphis Tennessee 38163 —
Vanderbilt Univ Med Ctr Nashville Tennessee 37203 —
Dr David Donnell Dallas Texas 75219 —
Nelson-Tebedo Community Clinic Dallas Texas 75219 —
Univ of Texas Med Branch Galveston Texas 77555 —
Montrose Clinic Houston Texas 77006 —
Baylor College of Medicine / Dept of Medicine Houston Texas 770303498 —
Univ of Texas / Med School at Houston Houston Texas 77030 —
Univ of Texas Health Sciences Ctr San Antonio Texas 782847838 —
Hampton Roads Med Specialists Hampton Virginia 23666 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00004852, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2005 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00004852 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →